VIVEbiotech is already at ISCT 2026 in Dublin
Connecting with partners and showcasing innovation in lentiviral vector manufacturing
VIVEbiotech is participating in the 2026 annual meeting of the ISCT (International Society for Cell & Gene Therapy), taking place from May 6 to 9 in Dublin, Ireland, one of the most relevant international events in the field of advanced therapies. The event, held at the Convention Centre Dublin (CCD), brings together experts, collaborators, and innovators from the cell and gene therapy ecosystem.
During these days, VIVEbiotech is holding meetings with various stakeholders in the sector to explore collaboration opportunities and share how its capabilities can support ex vivo and in vivo lentiviral vector development from early stages through to commercialization.
The VIVEbiotech team attending the event includes María Echeverría, Head of Upstream Development, and Miguel Álvarez, Business Development Manager.
As part of the scientific program, María, on behalf of the company, will present poster #979 entitled Scalable Cell Detachment Process Enabling Direct Seeding of Large-Scale 200 m² and 600 m² Bioreactors. The presentation will take place today from 7 PM to 8:30 PM at Level 4 (Auditorium).
Attendees interested in meeting with VIVEbiotech can still arrange meetings via the official partnering platform or contact the team directly through the website form.